Stay up to date on the FDA’s classification and regulatory requirements for skin patch devices intended to treat hyperhidrosis. This course covers the specifics of the final rule under 21 CFR 878.4425, including compliance strategies for manufacturers and sponsors. Learn about special controls, essential performance testing, labeling requirements, and the 510(k) process to ensure safe, effective, and market-ready products.
In this course you will learn the following:
* Understand the FDA’s rationale for classifying the skin patch for hyperhidrosis as a class II device.
* Identify the special controls and general controls applicable to this device type.
* Implement the required testing, labeling, and documentation to ensure compliance.
* Recognize the legal and regulatory consequences of failing to comply with the final rule.
